AnGes Financials
| AMGXF Stock | USD 0.36 0.00 0.00% |
With this module, you can analyze AnGes financials for your investing period. You should be able to track the changes in AnGes individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
AnGes |
Understanding current and past AnGes Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AnGes' financial statements are interrelated, with each one affecting the others. For example, an increase in AnGes' assets may result in an increase in income on the income statement.
The data published in AnGes' official financial statements typically reflect AnGes' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving AnGes' quantitative information. For example, before you start analyzing numbers published by AnGes accountants, it's essential to understand AnGes' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
AnGes Stock Summary
AnGes competes with Lexicon Pharmaceuticals, Blueprint Medicines, Day One, Halozyme Therapeutics, and Checkpoint Therapeutics. AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCGREY Exchange |
| Business Address | Saito Bio-Incubator, Ibaraki, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.anges.co.jp |
| Currency | USD - US Dollar |
AnGes Key Financial Ratios
There are many critical financial ratios that AnGes' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AnGes Inc reports annually and quarterly.AnGes Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AnGes's current stock value. Our valuation model uses many indicators to compare AnGes value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AnGes competition to find correlations between indicators driving AnGes's intrinsic value. More Info.AnGes Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AnGes' earnings, one of the primary drivers of an investment's value.AnGes Inc Systematic Risk
AnGes' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AnGes volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on AnGes Inc correlated with the market. If Beta is less than 0 AnGes generally moves in the opposite direction as compared to the market. If AnGes Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AnGes Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AnGes is generally in the same direction as the market. If Beta > 1 AnGes moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for AnGes OTC Stock analysis
When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |